inositol has been researched along with Fungal Diseases in 3 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "myo-Inositol (inositol) is an essential nutrient that is used for building phosphatidylinositol and its derivatives in eukaryotes and even in some eubacteria such as the mycobacteria." | 2.45 | Strategies for acquiring the phospholipid metabolite inositol in pathogenic bacteria, fungi and protozoa: making it and taking it. ( Reynolds, TB, 2009) |
| "Fungal infections are an increasing public health problem, particularly in immunocompromised individuals." | 1.46 | Extensive Metabolic Remodeling Differentiates Non-pathogenic and Pathogenic Growth Forms of the Dimorphic Pathogen ( Andrianopoulos, A; Boyce, KJ; Chambers, J; Chua, HH; MacRae, JI; McConville, MJ; Pasricha, S, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bankaitis, VA | 1 |
| Tripathi, A | 1 |
| Chen, XR | 1 |
| Igumenova, TI | 1 |
| Pasricha, S | 1 |
| MacRae, JI | 1 |
| Chua, HH | 1 |
| Chambers, J | 1 |
| Boyce, KJ | 1 |
| McConville, MJ | 1 |
| Andrianopoulos, A | 1 |
| Reynolds, TB | 1 |
2 reviews available for inositol and Fungal Diseases
| Article | Year |
|---|---|
New strategies for combating fungal infections: Inhibiting inositol lipid signaling by targeting Sec14 phosphatidylinositol transfer proteins.
Topics: Humans; Inositol; Mycoses; Phosphatidylinositols; Phospholipid Transfer Proteins; Saccharomyces cere | 2022 |
Strategies for acquiring the phospholipid metabolite inositol in pathogenic bacteria, fungi and protozoa: making it and taking it.
Topics: Animals; Bacteria; Bacterial Infections; Eukaryota; Fungi; Humans; Inositol; Mycoses; Phospholipids; | 2009 |
1 other study available for inositol and Fungal Diseases
| Article | Year |
|---|---|
Extensive Metabolic Remodeling Differentiates Non-pathogenic and Pathogenic Growth Forms of the Dimorphic Pathogen
Topics: Amino Acids; Animals; Carbohydrate Metabolism; Carbon; Citric Acid Cycle; Gene Expression Regulation | 2017 |